Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-30 @ 8:23 AM
Study NCT ID:
NCT01933334
Status:
COMPLETED
Last Update Posted:
2016-08-04
First Post:
2013-08-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10
Start Date Type:
None
Primary Completion Date:
2014-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-09
Completion Date Type:
ACTUAL
First Submit Date:
2013-08-23
First Submit QC Date:
None
Study First Post Date:
2013-09-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-08-25
Results First Submit QC Date:
None
Results First Post Date:
2015-09-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-07-06
Last Update Post Date:
2016-08-04
Last Update Post Date Type:
ESTIMATED